MARCKS and cancer: The present findings reveal a simple molecular mechanism hypothesized to underlie the ability of excessive phospho-MARCKS to trigger cancer, in which increased levels of phospho-MARCKS trigger higher free PIP2 levels that recruit additional active PI3K to the membrane, thereby increasing net PIP3 production.